Xanomeline
Xanomeline is a muscarinic acetylcholine receptor agonist that has been studied for its potential therapeutic uses, particularly in the treatment of Alzheimer's disease and schizophrenia. It was first synthesized in the late 20th century and has been the subject of numerous clinical trials.
History[edit | edit source]
Xanomeline was first synthesized in the 1990s by scientists at Lilly Research Laboratories. The compound was developed as a potential treatment for Alzheimer's disease and schizophrenia, due to its ability to stimulate muscarinic acetylcholine receptors in the brain.
Pharmacology[edit | edit source]
Xanomeline is a muscarinic acetylcholine receptor agonist. It has a high affinity for the M1 and M4 subtypes of this receptor, which are primarily found in the brain. By stimulating these receptors, xanomeline can increase the activity of the cholinergic system, which is often impaired in individuals with Alzheimer's disease and schizophrenia.
Clinical Trials[edit | edit source]
Several clinical trials have been conducted to evaluate the efficacy of xanomeline in treating Alzheimer's disease and schizophrenia. In a phase II trial conducted by Lilly Research Laboratories, xanomeline was found to improve cognitive function and reduce psychotic symptoms in patients with Alzheimer's disease. However, the drug also caused significant side effects, including nausea and increased salivation, which led to the discontinuation of the trial.
Current Status[edit | edit source]
As of 2021, xanomeline is not approved for use in any country. However, research into its potential therapeutic uses continues. A prodrug of xanomeline, known as KarXT, is currently being developed by Karuna Therapeutics for the treatment of schizophrenia and other psychiatric disorders.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
